0000899243-20-022197.txt : 20200812
0000899243-20-022197.hdr.sgml : 20200812
20200812210058
ACCESSION NUMBER: 0000899243-20-022197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200810
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kusserow Paul B. K.
CENTRAL INDEX KEY: 0001456688
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 201096839
MAIL ADDRESS:
STREET 1: 780 SAN YSIDRO ROAD
CITY: SANTA BARBARA
STATE: CA
ZIP: 93108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-10
0
0000896262
AMEDISYS INC
AMED
0001456688
Kusserow Paul B. K.
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
1
1
0
0
See Remarks
Common Stock
2020-08-10
4
M
0
250000
26.65
A
299092
D
Common Stock
2020-08-10
4
M
0
250000
26.78
A
549092
D
Common Stock
2020-08-10
4
F
0
231683
231.92
D
317409
D
Common Stock
101404
I
By Trust
Common Stock
621
I
Through 401(k) Plan
Stock Option (right to buy)
26.65
2020-08-10
4
M
0
250000
0.00
D
2015-12-16
2024-12-16
Common Stock
250000
0
D
Stock Option (right to buy)
26.78
2020-08-10
4
M
0
250000
0.00
D
2025-03-31
Common Stock
250000
0
D
The information in this report is based on a plan statement dated as of June 30, 2020.
The stock option vested in four equal annual installments on each of December 16, 2015, December 16, 2016, December 16, 2017 and December 16, 2018.
On March 31, 2015, the reporting person was granted an option to purchase 250,000 shares of common stock, which vested based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ended December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2015, 2016, 2017 and 2018 were met, resulting in vesting of the option as to all 250,000 shares.
CEO, President and Chairman of the Board
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2020-08-12